BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25632377)

  • 1. Recent Advances in Metabolic Profiling And Imaging of Prostate Cancer.
    Thapar R; Titus MA
    Curr Metabolomics; 2014 Apr; 2(1):53-69. PubMed ID: 25632377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiling of oesophago-gastric cancer: a systematic review.
    Abbassi-Ghadi N; Kumar S; Huang J; Goldin R; Takats Z; Hanna GB
    Eur J Cancer; 2013 Nov; 49(17):3625-37. PubMed ID: 23896378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.
    Zheng H; Dong B; Ning J; Shao X; Zhao L; Jiang Q; Ji H; Cai A; Xue W; Gao H
    Clin Chim Acta; 2020 Feb; 501():241-251. PubMed ID: 31758937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice.
    Calvani R; Brasili E; Praticò G; Capuani G; Tomassini A; Marini F; Sciubba F; Finamore A; Roselli M; Marzetti E; Miccheli A
    Exp Gerontol; 2014 Jan; 49():5-11. PubMed ID: 24184118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.
    Hirayama A; Kami K; Sugimoto M; Sugawara M; Toki N; Onozuka H; Kinoshita T; Saito N; Ochiai A; Tomita M; Esumi H; Soga T
    Cancer Res; 2009 Jun; 69(11):4918-25. PubMed ID: 19458066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR-Based Prostate Cancer Metabolomics.
    Euceda LR; Andersen MK; Tessem MB; Moestue SA; Grinde MT; Bathen TF
    Methods Mol Biol; 2018; 1786():237-257. PubMed ID: 29786797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of prostate cancer by magnetic resonance spectroscopy (MRS).
    Sharma U; Jagannathan NR
    Biophys Rev; 2020 Oct; 12(5):1163-1173. PubMed ID: 32918707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
    Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
    Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Mass Spectrometry and NMR Improves Metabolite Detection and Annotation.
    Bhinderwala F; Wase N; DiRusso C; Powers R
    J Proteome Res; 2018 Nov; 17(11):4017-4022. PubMed ID: 30303385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and Perspectives.
    Letertre MPM; Giraudeau P; de Tullio P
    Front Mol Biosci; 2021; 8():698337. PubMed ID: 34616770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.
    Li M; Wang X; Aa J; Qin W; Zha W; Ge Y; Liu L; Zheng T; Cao B; Shi J; Zhao C; Wang X; Yu X; Wang G; Liu Z
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1317-24. PubMed ID: 23467425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic investigation of Arthus reaction in a rat model using proton nuclear magnetic resonance (1H NMR) spectroscopy and rapid resolution liquid chromatography (RRLC).
    Zhang X; Shen J; Cao B; Xu L; Zhao T; Liu X; Zhang H
    Mol Biosyst; 2013 Jun; 9(6):1423-35. PubMed ID: 23511749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
    Patel S; Ahmed S
    J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics of cancer.
    Serkova NJ; Glunde K
    Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.